[1]
V. Divino, BA, M. S. Cepeda, MD, PhD, P. Coplan, ScD, MBA, MPH, J.-Y. Maziere, MD, PhD, Y. Yuan, PhD, and R. L. Wade, RPh, MS, “Assessing the impact of the extended-release/long-acting opioid analgesics risk evaluation and mitigation strategies on opioid prescription volume”, J of Opioid Management, vol. 13, no. 3, pp. 157–168, May 2017.